Invidia Capital Management

Invidia Capital Management is a New York-based dedicated healthcare investment firm backing entrepreneurs focused on improving clinical outcomes and patient access. The firm operates within Care Delivery and tech-enabled services rather than pure software. AI is not a dedicated thesis, and Invidia’s identity is closer to a specialized growth equity firm than a generalist sponsor. Limited public AUM information is reflected in the source data.

Check sizes are $5M-$25M at the growth stage, suitable for minority growth and lower-middle-market control investments. Geographic deployment is primarily U.S. Specific portfolio companies are not listed in the source data. Diligence emphasizes clinical outcomes data, patient access metrics, payor diversity, and the operational maturity of the management team.

For founders, Invidia is relevant when running a clinically validated services business with measurable outcomes and a need for $5-25M of growth capital. It is the wrong fit for a pre-revenue AI tool. The right profile is a physician-founder or experienced operator who can demonstrate both improved patient outcomes and a credible expansion plan into new geographies, payor relationships, or service lines.